Skip to main content
HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · Real-Time Price · USD
14.22
+0.06 (0.42%)
Dec 5, 2025, 4:00 PM EST - Market closed

Revenue by Product

Fiscal year is January - December.
Year Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 NaN - NaN
Oncology/Immunology - Marketed Products
2.12B
Log In
Log In
Log In
Log In
Upgrade
Oncology/Immunology - Marketed Products Growth
64.85%
Log In
Log In
Log In
Log In
Upgrade
Other Ventures
2.08B
Log In
Log In
Log In
Log In
Upgrade
Other Ventures Growth
-14.04%
Log In
Log In
Log In
Log In
Upgrade
Oncology/Immunology - Research and Development
716.55M
Log In
Log In
Log In
Log In
Upgrade
Oncology/Immunology - Research and Development Growth
-74.89%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Year Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 NaN - NaN
China
3.53B
Log In
Log In
Log In
Log In
Upgrade
China Growth
-7.01%
Log In
Log In
Log In
Log In
Upgrade
United States and Others
1.39B
Log In
Log In
Log In
Log In
Upgrade
United States and Others Growth
-49.82%
Log In
Log In
Log In
Log In
Upgrade